Literature DB >> 24122183

Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies.

Haruhiko Oda1, Kazunari Ishii, Akira Terashima, Ken-Ichi Shimada, Yumiko Yamane, Ryota Kawasaki, Shingo Ohkawa.   

Abstract

OBJECTIVE: To compare the usefulness of brain perfusion SPECT and (123)I-metaiodobenzylguanidine ((123)I-MIBG) in predicting the conversion of possible dementia with Lewy bodies (DLB) to probable DLB.
METHODS: We examined 94 patients with possible DLB based on the Consensus Criteria for the Clinical Diagnosis of DLB by N-Isopropyl-p-(123)I-iodoamphetamine ((123)I-IMP) brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy. After 1 year of follow-up, 33 of 94 patients met the criteria for probable DLB. (123)I-IMP brain perfusion SPECT and (123)I-MIBG myocardial scintigraphy were tested as predictors of the conversion from possible DLB to probable DLB. A receiver operating characteristic (ROC) analysis was performed.
RESULTS: The areas under the ROC curves for SPECT for predicting the conversion to probable DLB from possible DLB based on the occipital/cerebellum and occipital/striatum cortex ratios of blood flow counts were 0.591 and 0.585, respectively. The areas under the ROC curves for (123)I-MIBG based on the early heart to mediastinum (H/M) ratio, delayed H/M ratio, and washout rate were 0.935, 0.936, and 0.884, respectively.
CONCLUSION: (123)I-MIBG myocardial scintigraphy is a good predictor of the future conversion of possible DLB to probable DLB.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24122183     DOI: 10.1212/01.wnl.0000435553.67953.81

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.

Authors:  Iñigo Gabilondo; Verónica Llorens; Trinidad Rodriguez; Manuel Fernández; Tomas Pérez Concha; Marian Acera; Beatriz Tijero; Ane Murueta-Goyena; Rocío Del Pino; Jesús Cortés; Juan Carlos Gómez-Esteban
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-15       Impact factor: 9.236

Review 2.  Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus.

Authors:  Kazunari Ishii
Journal:  Jpn J Radiol       Date:  2019-09-23       Impact factor: 2.374

Review 3.  (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.

Authors:  Eun Joo Chung; Sang Jin Kim
Journal:  J Mov Disord       Date:  2015-05-31

4.  On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.

Authors:  Hayato Odagiri; Toru Baba; Yoshiyuki Nishio; Osamu Iizuka; Minoru Matsuda; Kentaro Inoue; Akio Kikuchi; Takafumi Hasegawa; Masashi Aoki; Atsushi Takeda; Yasuyuki Taki; Etsuro Mori
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

Review 5.  A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment.

Authors:  Samuel D Capouch; Martin R Farlow; Jared R Brosch
Journal:  Neurol Ther       Date:  2018-07-09

6.  Neuroimaging alterations in dementia with Lewy bodies and neuroimaging differences between dementia with Lewy bodies and Alzheimer's disease: An activation likelihood estimation meta-analysis.

Authors:  Wen-Ying Ma; Min-Jie Tian; Qun Yao; Qian Li; Fan-Yu Tang; Chao-Yong Xiao; Jing-Ping Shi; Jiu Chen
Journal:  CNS Neurosci Ther       Date:  2021-12-06       Impact factor: 5.243

Review 7.  Neuroimaging in Lewy body dementia.

Authors:  Tayyabah Yousaf; George Dervenoulas; Polytimi-Eleni Valkimadi; Marios Politis
Journal:  J Neurol       Date:  2018-05-14       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.